Opinion – Tuesday 3 November 2020

U.S Indices closed higher, boosted by strong economic data, as they rebounded following a bad week and a down October. The ISM Manufacturing Index came in above estimates in October, and hit the highest level since September 2018. And IHS Markit Manufacturing PMI rose...

Opinion – Monday 2 November 2020

U.S. Equity Markets declined again on Friday and in the process registering its worst week since March. The S&P closed 1.21% lower while following the weaker than expected earnings from Apple, the NASDAQ 100 led the declines with a loss of 2.62%. COVID-19 trends...

Opinion – Friday 30 October 2020

U.S. Equity Markets rebounded after yesterday’s sell-off, finishing the day positive with the S&P 500 closing higher by 1.2% and the NASDAQ 100 +1.87%. Speaker of the House Nancy Pelosi said the terms of a Coronavirus Stimulus Bill could change if the...

Opinion – Thursday 29 October 2020

U.S. Equity Markets sold off sharply, finishing the day lower, with the S&P 500 -3.52%, the Dow -3.42% and the NASDAQ 100 -3.93%. Coronavirus case numbers, and the fears of more restrictions that come with them, remained the key driver of the sell-off. In terms...

Opinion – Wednesday 28 October 2020

U.S. Equity Markets were mixed for most of the day, before selling off into the close, finishing the day lower, led by the Dow which closed -0.80%. Treasury Secretary Steven Mnuchin and Speaker of the House Nancy Pelosi failed to resolve differences on stimulus...

Opinion – Tuesday 27 October 2020

U.S. Equity Markets tumbled as Coronavirus cases rose, finishing the day lower, led by the Dow which closed with a loss of 2.29%. Coronavirus infections rose to new highs, as the daily total breached the 80,000 mark for the first time. The seven-day average hit a new...

Opinion – Friday 23 October 2020

U.S. Equity markets rose again on positive stimulus developments, finishing the day higher, led by the Dow which closed with a gain of +0.55%. House Speaker Nancy Pelosi said that negotiations between the White House and Democrats were “just about there.”...

Opinion – Thursday 22 October 2020

U.S. Equity Markets were mixed as investors digested Stimulus headlines, but finished lower after a volatile trading session. White House Chief of Staff Mark Meadows said he is hopeful the GOP and Democrats can reach a Stimulus Agreement by this weekend. But Senate...

Opinion – Wednesday 21 October 2020

U.S Indices closed higher as Stimulus hopes boosted markets. Yesterday was a volatile trading session with plenty of two-way price action with markets closing well off their intra-day high. Speaker of the House Nancy Pelosi’s office said she and Treasury...

Opinion – Tuesday 20 October 2020

U.S Markets rose at the open, before falling in a volatile trading session as the S&P closed 1.63% lower. Stimulus headlines were mixed, after Speaker of the House Nancy Pelosi said she is hopeful a Stimulus deal will be signed before the election despite...

Opinion – Monday 19 October 2020

U.S. Equity Markets rebounded for most of the day, but finished Friday weak, after their sell-off over the previous few days. Economic data was mixed. Retail Sales rose by more than expected, in a positive note for consumer spending. That is the fifth straight month...

Opinion – Friday 16 October 2020

U.S Indices closed lower for the third consecutive trading session as fears of a stalling job market recovery weighed on markets. New Initial Jobless Claims reached 898,000 in the week ending October 10, according to the Department of Labour. This was an increase from...

Opinion – Thursday 15 October 2020

U.S Indices closed lower for the second consecutive session as COVID-19 continues to weigh on investor sentiment. Drug manufacturer Eli Lilly’s Coronavirus treatment trial was placed on hold after an independent monitoring board recommended suspending enrolment...

Opinion – Wednesday 14 October 2020

After rallying over 6% in just four trading session, the S&P closed 0.63% lower as COVID-19 vaccine concerns weighed on markets. Johnson & Johnson announced that its vaccine trial had been paused after one of the patients came down with an unexplained...